VIICTR
Profiles
ORIT
Pediatrics CRA
Home
About
Overview
Sharing Data
ORCID
Help
History (1)
The impact of targeted molecular therapies on the level of renal cell carcinoma vena caval tumor thrombus.
See All Pages
Find People
Find Everything
Login
to edit your profile (add a photo, awards, links to other websites, etc.)
Edit My Profile
My Person List (
0
)
Return to Top
The impact of targeted molecular therapies on the level of renal cell carcinoma vena caval tumor thrombus.
The impact of targeted molecular therapies on the level of renal cell carcinoma vena caval tumor thrombus. Eur Urol. 2011 Jun; 59(6):912-8.
View in:
PubMed
subject areas
Adult
Aged
Angiogenesis Inhibitors
Antibodies, Monoclonal
Antibodies, Monoclonal, Humanized
Bevacizumab
Carcinoma, Renal Cell
Chemotherapy, Adjuvant
Chi-Square Distribution
Drug Administration Schedule
Female
Humans
Indoles
Kidney Neoplasms
Male
Middle Aged
Molecular Targeted Therapy
Neoadjuvant Therapy
Neoplasm Invasiveness
Neoplasm Staging
Nephrectomy
Patient Selection
Proportional Hazards Models
Protein Kinase Inhibitors
Pyrroles
Radiography
Retrospective Studies
Risk Assessment
Risk Factors
Texas
Thrombectomy
Time Factors
Treatment Outcome
Tumor Burden
Vena Cava, Inferior
Venous Thrombosis
authors with profiles
CHRISTOPHER G WOOD
JOSE ANTONIO KARAM
BRIAN FRANCIS CHAPIN